
As weight-loss medications become increasingly common, a clinical trial suggests that three weekly strength-training sessions could help people preserve muscle and maintain physical independence.
Losing weight is often the goal for people taking medications such as Ozempic and Mounjaro, but the number on the scale does not tell the whole story.
A new study found that adults taking a powerful weight-loss drug shed nearly 50 pounds in 40 weeks, regardless of whether they exercised. Those who also lifted weights, however, preserved more lean tissue and became stronger, while participants who did not train experienced a decline in strength.
The findings address a growing concern surrounding medications such as semaglutide (Ozempic and Wegovy) and tirzepatide (Mounjaro). These drugs can produce substantial weight loss and have been found to improve chronic health conditions, reduce the risk of obesity-related cardiovascular disease, and enhance quality of life. However, losing so much weight raises questions about how much muscle people might lose along the way.
Weight loss can come at a cost to muscle
“Loss of lean mass, including muscle, is an inevitable part of weight loss by any method – whether through diet and exercise alone, or medical or surgical interventions,” said Winthrop Professor Danny Green, lead investigator from The University of Western Australia’s School of Human Sciences and HealthSpan Institute.
Lean mass includes everything in the body other than fat, such as muscles, bones, organs, skin, and water. Muscle mass refers specifically to muscle tissue, mostly skeletal muscle. Preserving that tissue is particularly important for people hoping to maintain their strength and physical independence as they lose weight.
“With GLP-1 medicines now widely used and reducing body weight by an average of 20-25 percent, and more than that in many people, it’s crucial that we understand how best to achieve optimal body composition and health in the weight-reduced state.”
Testing weight training alongside tirzepatide
To investigate whether exercise could help, researchers conducted the Tirzepatide and Resistance Exercise (T-REx) study, published in Nature Medicine. It is the first study to examine the combined effects of a GLP-1 medication and resistance training on body composition, muscle mass, strength, and a range of cardiovascular health measures.
The 40-week trial involved 120 men and postmenopausal women between the ages of 50 and 70. All participants had obesity or were overweight with at least one weight-related health condition. None had type 2 diabetes, and all were prescribed tirzepatide for weight management.
Half the participants completed three resistance-training sessions each week, while the others did not follow a resistance-training program. Everyone received general guidance on hydration, protein consumption, and fiber intake.
By the end of the study, both groups had experienced substantial weight loss. Participants who exercised lost an average of 22.28 kilograms (49.1 pounds), compared with 22.61 kilograms (49.8 pounds) among those who did not train.
Most of that weight loss came from fat. The resistance-training group lost an average of 17.98 kilograms (39.6 pounds) of fat mass, while the group without resistance training lost 17.19 kilograms (37.9 pounds).
Similar weight loss, opposite strength changes
The more meaningful difference emerged when researchers examined lean tissue and physical strength. Participants who lifted weights lost 25 percent less lean tissue, including muscle, than those who did not exercise. Their upper- and lower-body strength also increased by 10 percent, compared with a 10 percent decline among participants who did not undertake resistance training.
“We now know that muscle loss can be reduced and strength increased when regular resistance training is used alongside tirzepatide treatment.”
Could strength gains mean healthier years?
For Green, the results suggest that resistance exercise should be part of the prescription for people taking weight-loss medications such as tirzepatide. The goal, he explained, should extend beyond reaching a lower body weight to maintaining the physical abilities that support long-term health.
“This study shows that combining weight loss therapy and resistance exercise improves overall health,” Professor Green said.
“In theory, that should translate to a longer healthspan, the number of healthy, independent, and productive years of life that are lived free from debilitating chronic diseases.”
Whether these improvements ultimately translate into more years of healthy, independent living remains to be established. However, the findings suggest that resistance training can help people achieve a more favorable balance between weight loss, lean tissue preservation, and strength during tirzepatide treatment.
Reference: “Resistance exercise to attenuate lean mass loss during tirzepatide therapy for obesity: a randomized controlled trial” by Daniel J. Green, Andrew Haynes, Destiny R. Underwood, Evangeline R. Winterton, Abbey A. Green, Robin M. Daly, Elena S. George, Leanne Lester, Louise H. Naylor, Graham S. Hillis, P. Gerry Fegan and Bu B. Yeap, 9 November 2026, Nature Medicine.
DOI: 10.1038/s41591-026-04752-5
Never miss a breakthrough: Join the SciTechDaily newsletter.
Follow us on Google and Google News.
1 Comment
EVERYONE NEEDS SALVATION HERE ARE THE WORDS OF SALVATION PLEASE FORGIVE ME JESUS IM A SINNER COME INTO MY HEART AND SAVE ME FROM MY SIN I NO THAT YOU ARE THE SAVIOR AND I NO THAT YOU DIED FOR ME ON CALVARY AND I NO THAT GOD RAISE YOU FROM THE DEAD AND YOU ARE ALIVE AND I THANKYOU FOR YOUR SALVATION IN JESUS HOLY NAME AMEN AND ITS IMPORTANT TO ALWAYS ASK FOR FORGIVENESS EVERY NIGHT AND HOPE SOMEONE GETS SAVED ITS IMPORTANT